Martin et al. identified WASL as a potential tumor suppressor gene in breast cancer [24]; WASL is lowly expressed in intestinal cancer tissues and cells and is associated with poor prognosis of intestinal cancer [25]. This evidence concerns the gene WASL and breast carcinoma.